FNYS
CLLS

First New York Securities’s Cellectis CLLS Stock Holding History

First New York Securities’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,341
Closed -$64.4K – 227
2016
Q1 		$64.4K Buy
+2,341
New +$56.4K 0.04% 105
2015
Q3 		– Sell
-500
Closed -$18K – 362
2015
Q2 		$18K Buy
+500
New +$17.6K 0.01% 278

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
THSP
Taube Hodson Stonex Partners London, United Kingdom $488M AUM 4.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

First New York Securities's CLLS Position: Q2 2016 in Review

First New York Securities sold out of Cellectis (CLLS) in Q2 2016, closing a stake of 2,341 shares — an estimated $64.4K sold.

First New York Securities first reported a position in CLLS in Q2 2015 and held it in 2 quarters. The position peaked at $64.4K in Q1 2016. 38 funds tracked by Wall St. Rank hold CLLS as of Q2 2016.

  • First New York Securities reported no remaining Cellectis position as of Q2 2016 after selling out during the quarter.
  • First New York Securities sold 2,341 Cellectis shares in Q2 2016, an estimated $64.4K.
  • First New York Securities first reported a position in Cellectis in Q2 2015 and held it in 2 quarters.
  • First New York Securities's Cellectis position peaked at $64.4K in Q1 2016.
  • 38 funds tracked by Wall St. Rank held Cellectis as of Q2 2016.

Based on First New York Securities's 13F filing for Q2 2016, filed 27 Jul 2016.